Zydus Wellness Ltd
NSE:ZYDUSWELL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 473.85
2 397.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Zydus Wellness Ltd
Zydus Wellness Ltd
Cost of Revenue
Zydus Wellness Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zydus Wellness Ltd
NSE:ZYDUSWELL
|
Cost of Revenue
-₹12B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-26%
|
|
|
Tata Consumer Products Ltd
NSE:TATACONSUM
|
Cost of Revenue
-₹90.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-9%
|
|
|
Britannia Industries Ltd
NSE:BRITANNIA
|
Cost of Revenue
-₹97.7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Patanjali Foods Ltd
NSE:PATANJALI
|
Cost of Revenue
-₹285.5B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Marico Ltd
NSE:MARICO
|
Cost of Revenue
-₹48.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
Nestle India Ltd
NSE:NESTLEIND
|
Cost of Revenue
-₹84.3B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
Zydus Wellness Ltd
Glance View
Zydus Wellness Ltd. weaves its narrative by fusing health-conscious innovation with strategic market positioning. Originating as an offshoot of the pharmaceutical giant Cadila Healthcare, Zydus Wellness was established to harness the rising tide of the wellness revolution in India. At the heart of its portfolio are brands like Sugar Free, Everyuth, and Nutralite, each carefully cultivated to address specific consumer demands for healthier lifestyle choices. Sugar Free, a leader in the artificial sweetener space, capitalizes on the growing diabetic and diet-conscious population, while Everyuth's exfoliating and skincare ranges tap into beauty and personal care. Meanwhile, Nutralite tackles the shift towards healthier dietary options with its line of cholesterol-free butter alternatives. This diverse portfolio highlights Zydus Wellness’s grasp of consumer insights and its ability to align product innovation with societal trends. The company’s financial tapestry is woven from the threads of brand loyalty and expansive distribution channels. Its approach deftly combines strong marketing strategies with a robust distribution framework, ensuring that its products readily reach varied consumer bases across urban and rural landscapes. Zydus Wellness leverages its relationship with Zydus Cadila to benefit from shared resources and synergies in research and development, enhancing its capacity for product refinement and innovation. This symbiotic relationship strengthens its market presence and supports its financial growth. By effectively managing its brand portfolio and continuously expanding its market reach, Zydus Wellness not only sustains its revenue streams but also solidifies its standing in the competitive wellness segment. Through strategic foresight and customer-centric product evolution, Zydus Wellness navigates the dynamic landscape, thriving amidst the increasing consumer gravitation towards healthier alternatives.
See Also
What is Zydus Wellness Ltd's Cost of Revenue?
Cost of Revenue
-12B
INR
Based on the financial report for Sep 30, 2024, Zydus Wellness Ltd's Cost of Revenue amounts to -12B INR.
What is Zydus Wellness Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-26%
Over the last year, the Cost of Revenue growth was -3%. The average annual Cost of Revenue growth rates for Zydus Wellness Ltd have been -9% over the past three years , -14% over the past five years , and -26% over the past ten years .
You don't have any saved screeners yet